Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -11.110\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a. CCc1nn(C(CC)C(=O)NCCCN2CC(C)CC(C)C2)c(=O)c2cc3oc(C)cc3n12
b. COC(=O)C1=C(c2cccc(Cl)c2)C[C@@H]2CC[C@H]1N2C(=O)N1CCCC1
c. O=C(CSc1nnc(-c2ccccc2)n1-c1ccccc1)c1ccc[nH]1
d. C#CCCC(=O)c1ccccc1/C=[N+](\[O-])c1ccccc1
e. COc1ccc(Nc2nc(N)c([N+](=O)[O-])c(NC3CCCCC3)n2)cc1
Answer: a. CCc1nn(C(CC)C(=O)NCCCN2CC(C)CC(C)C2)c(=O)c2cc3oc(C)cc3n12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCc1nn(C(CC)C(=O)NCCCN2CC(C)CC(C)C2)c(=O)c2cc3oc(C)cc3n12
CCc1nn(C(CC)C(=O)NCCCN2CC(C)CC(C)C2)c(=O)c2cc3oc(C)cc3n12
N-[3-(3,5-dimethylpiperidin-1-yl)propyl]-2-(12-ethyl-4-methyl-9-oxo-5-oxa-1,10,11-triazatricyclo[6.4.0.02,6]dodeca-2(6),3,7,11-tetraen-10-yl)butanamide